3 days popular7 days popular1 month popular3 months popular

Molecular imaging study reveals improved detection of early recurrent prostate cancer

A recently developed drug was significantly better at detecting recurring prostate cancer in early stages, in research published in the August 2015 issue of The Journal of Nuclear Medicine. In the study, the imaging agent–Ga-68 prostate-specific membrane antigen (Ga-68 PSMA)–used with positron emission tomography and computed tomography (PET/CT), changed management in 44% more cases than [...]

Myriad validates active surveillance threshold with Prolaris® for men with prostate cancer

Additional data show Prolaris changed treatment plans in 48 percent of cases Myriad Genetics, Inc. (NASDAQ: MYGN) presented clinical data for its Prolaris test at the 2015 American Urological Association (AUA) Annual Meeting being held May 15 to 19 in New Orleans, La. The results highlighted and underscored the significant ability of the Prolaris test [...]

Moffitt researchers work to determine why some prostate cancer patients experience more hot flashes

New study shows men who are younger or have a lower body mass index are more prone to experience hot flashes during androgen deprivation therapy Androgen deprivation therapy (ADT) is a common treatment option for patients with advanced stage prostate cancer. But nearly 80 percent of patients who receive ADT report experiencing hot flashes during [...]

Patients with detectable PSA post-prostatectomy should receive more aggressive radiation therapy

Ten-year post-treatment analysis of German ARO 96-02 Prostate cancer patients with detectable prostate specific antigen (PSA) following radical prostatectomy should receive earlier, more aggressive radiation therapy treatment, according to a study published in the International Journal of Radiation Oncology * Biology * Physics (Red Journal), the official scientific journal of the American Society for Radiation [...]

In prostate cancer patients carrying ‘BRCA’ mutations, conventional therapies are less efficient

Prostate cancer patients carrying inherited mutations in the BRCA genes respond less well to conventional treatment, including surgery and/or radiotherapy – and they also have a lower survival rate than those who are non-carriers of these genetic mutations. Data from the study, which has been published in the journal European Urology, points to the need [...]